Cargando…

Development and validation of a nomogram to predict failure of 14-day negative nucleic acid conversion in adults with non-severe COVID-19 during the Omicron surge: a retrospective multicenter study

BACKGROUND: With the variability in emerging data, guidance on the isolation duration for patients with coronavirus disease 2019 (COVID-19) due to the Omicron variant is controversial. This study aimed to determine the predictors of prolonged viral RNA shedding in patients with non-severe COVID-19 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gui, Honglian, Zhang, Zhenglan, Chen, Bin, Chen, Yaoxing, Wang, Yue, Long, Zhuo, Zhu, Chuanwu, Wang, Yinling, Cao, Zhujun, Xie, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902821/
https://www.ncbi.nlm.nih.gov/pubmed/36750862
http://dx.doi.org/10.1186/s40249-023-01057-4
_version_ 1784883344634281984
author Gui, Honglian
Zhang, Zhenglan
Chen, Bin
Chen, Yaoxing
Wang, Yue
Long, Zhuo
Zhu, Chuanwu
Wang, Yinling
Cao, Zhujun
Xie, Qing
author_facet Gui, Honglian
Zhang, Zhenglan
Chen, Bin
Chen, Yaoxing
Wang, Yue
Long, Zhuo
Zhu, Chuanwu
Wang, Yinling
Cao, Zhujun
Xie, Qing
author_sort Gui, Honglian
collection PubMed
description BACKGROUND: With the variability in emerging data, guidance on the isolation duration for patients with coronavirus disease 2019 (COVID-19) due to the Omicron variant is controversial. This study aimed to determine the predictors of prolonged viral RNA shedding in patients with non-severe COVID-19 and construct a nomogram to predict patients at risk of 14-day PCR conversion failure. METHODS: Adult patients with non-severe COVID-19 were enrolled from three hospitals of eastern China in Spring 2022. Viral shedding time (VST) was defined as either the day of the first positive test or the day of symptom onset, whichever was earlier, to the date of the first of two consecutively negative PCR tests. Patients from one hospital (Cohort I, n = 2033) were randomly grouped into training and internal validation sets. Predictors of 14-day PCR conversion failure were identified and a nomogram was developed by multivariable logistic regression using the training dataset. Two hospitals (Cohort II, n = 1596) were used as an external validation set to measure the performance of this nomogram. RESULTS: Of the 2033 patients from Cohort I, the median VST was 13.0 (interquartile range: 10.0‒16.0) days; 716 (35.2%) lasted > 14 days. In the training set, increased age [per 10 years, odds ratio (OR) = 1.29, 95% confidence interval (CI): 1.15‒1.45, P < 0.001] and high Charlson comorbidity index (OR = 1.25, 95% CI: 1.08‒1.46, P = 0.004) were independent risk factors for VST > 14 days, whereas full or boosted vaccination (OR = 0.63, 95% CI: 0.42‒0.95, P = 0.028) and antiviral therapy (OR = 0.56, 95% CI: 0.31‒0.96, P = 0.040) were protective factors. These predictors were used to develop a nomogram to predict VST > 14 days, with an area under the ROC curve (AUC) of 0.73 in the training set (AUC, 0.74 in internal validation set; 0.76 in external validation set). CONCLUSIONS: Older age, increasing comorbidities, incomplete vaccinations, and lack of antiviral therapy are risk factors for persistent infection with Omicron variant for > 14 days. A nomogram based on these predictors could be used as a prediction tool to guide treatment and isolation strategies. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-9902821
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99028212023-02-07 Development and validation of a nomogram to predict failure of 14-day negative nucleic acid conversion in adults with non-severe COVID-19 during the Omicron surge: a retrospective multicenter study Gui, Honglian Zhang, Zhenglan Chen, Bin Chen, Yaoxing Wang, Yue Long, Zhuo Zhu, Chuanwu Wang, Yinling Cao, Zhujun Xie, Qing Infect Dis Poverty Research Article BACKGROUND: With the variability in emerging data, guidance on the isolation duration for patients with coronavirus disease 2019 (COVID-19) due to the Omicron variant is controversial. This study aimed to determine the predictors of prolonged viral RNA shedding in patients with non-severe COVID-19 and construct a nomogram to predict patients at risk of 14-day PCR conversion failure. METHODS: Adult patients with non-severe COVID-19 were enrolled from three hospitals of eastern China in Spring 2022. Viral shedding time (VST) was defined as either the day of the first positive test or the day of symptom onset, whichever was earlier, to the date of the first of two consecutively negative PCR tests. Patients from one hospital (Cohort I, n = 2033) were randomly grouped into training and internal validation sets. Predictors of 14-day PCR conversion failure were identified and a nomogram was developed by multivariable logistic regression using the training dataset. Two hospitals (Cohort II, n = 1596) were used as an external validation set to measure the performance of this nomogram. RESULTS: Of the 2033 patients from Cohort I, the median VST was 13.0 (interquartile range: 10.0‒16.0) days; 716 (35.2%) lasted > 14 days. In the training set, increased age [per 10 years, odds ratio (OR) = 1.29, 95% confidence interval (CI): 1.15‒1.45, P < 0.001] and high Charlson comorbidity index (OR = 1.25, 95% CI: 1.08‒1.46, P = 0.004) were independent risk factors for VST > 14 days, whereas full or boosted vaccination (OR = 0.63, 95% CI: 0.42‒0.95, P = 0.028) and antiviral therapy (OR = 0.56, 95% CI: 0.31‒0.96, P = 0.040) were protective factors. These predictors were used to develop a nomogram to predict VST > 14 days, with an area under the ROC curve (AUC) of 0.73 in the training set (AUC, 0.74 in internal validation set; 0.76 in external validation set). CONCLUSIONS: Older age, increasing comorbidities, incomplete vaccinations, and lack of antiviral therapy are risk factors for persistent infection with Omicron variant for > 14 days. A nomogram based on these predictors could be used as a prediction tool to guide treatment and isolation strategies. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2023-02-07 /pmc/articles/PMC9902821/ /pubmed/36750862 http://dx.doi.org/10.1186/s40249-023-01057-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Gui, Honglian
Zhang, Zhenglan
Chen, Bin
Chen, Yaoxing
Wang, Yue
Long, Zhuo
Zhu, Chuanwu
Wang, Yinling
Cao, Zhujun
Xie, Qing
Development and validation of a nomogram to predict failure of 14-day negative nucleic acid conversion in adults with non-severe COVID-19 during the Omicron surge: a retrospective multicenter study
title Development and validation of a nomogram to predict failure of 14-day negative nucleic acid conversion in adults with non-severe COVID-19 during the Omicron surge: a retrospective multicenter study
title_full Development and validation of a nomogram to predict failure of 14-day negative nucleic acid conversion in adults with non-severe COVID-19 during the Omicron surge: a retrospective multicenter study
title_fullStr Development and validation of a nomogram to predict failure of 14-day negative nucleic acid conversion in adults with non-severe COVID-19 during the Omicron surge: a retrospective multicenter study
title_full_unstemmed Development and validation of a nomogram to predict failure of 14-day negative nucleic acid conversion in adults with non-severe COVID-19 during the Omicron surge: a retrospective multicenter study
title_short Development and validation of a nomogram to predict failure of 14-day negative nucleic acid conversion in adults with non-severe COVID-19 during the Omicron surge: a retrospective multicenter study
title_sort development and validation of a nomogram to predict failure of 14-day negative nucleic acid conversion in adults with non-severe covid-19 during the omicron surge: a retrospective multicenter study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902821/
https://www.ncbi.nlm.nih.gov/pubmed/36750862
http://dx.doi.org/10.1186/s40249-023-01057-4
work_keys_str_mv AT guihonglian developmentandvalidationofanomogramtopredictfailureof14daynegativenucleicacidconversioninadultswithnonseverecovid19duringtheomicronsurgearetrospectivemulticenterstudy
AT zhangzhenglan developmentandvalidationofanomogramtopredictfailureof14daynegativenucleicacidconversioninadultswithnonseverecovid19duringtheomicronsurgearetrospectivemulticenterstudy
AT chenbin developmentandvalidationofanomogramtopredictfailureof14daynegativenucleicacidconversioninadultswithnonseverecovid19duringtheomicronsurgearetrospectivemulticenterstudy
AT chenyaoxing developmentandvalidationofanomogramtopredictfailureof14daynegativenucleicacidconversioninadultswithnonseverecovid19duringtheomicronsurgearetrospectivemulticenterstudy
AT wangyue developmentandvalidationofanomogramtopredictfailureof14daynegativenucleicacidconversioninadultswithnonseverecovid19duringtheomicronsurgearetrospectivemulticenterstudy
AT longzhuo developmentandvalidationofanomogramtopredictfailureof14daynegativenucleicacidconversioninadultswithnonseverecovid19duringtheomicronsurgearetrospectivemulticenterstudy
AT zhuchuanwu developmentandvalidationofanomogramtopredictfailureof14daynegativenucleicacidconversioninadultswithnonseverecovid19duringtheomicronsurgearetrospectivemulticenterstudy
AT wangyinling developmentandvalidationofanomogramtopredictfailureof14daynegativenucleicacidconversioninadultswithnonseverecovid19duringtheomicronsurgearetrospectivemulticenterstudy
AT caozhujun developmentandvalidationofanomogramtopredictfailureof14daynegativenucleicacidconversioninadultswithnonseverecovid19duringtheomicronsurgearetrospectivemulticenterstudy
AT xieqing developmentandvalidationofanomogramtopredictfailureof14daynegativenucleicacidconversioninadultswithnonseverecovid19duringtheomicronsurgearetrospectivemulticenterstudy